GANX
Gain Therapeutics Inc
NASDAQ: GANX · HEALTHCARE · BIOTECHNOLOGY
$1.76
-4.86% today
Updated 2026-04-29
Market cap
$83.70M
P/E ratio
—
P/S ratio
255.50x
EPS (TTM)
$-0.61
Dividend yield
—
52W range
$1 – $4
Volume
0.7M
Gain Therapeutics Inc (GANX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20609.00 | $41301.00 | $28881.00 | $133928.00 | $132640.00 | $55180.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +100.4% | -30.1% | +363.7% | -1.0% | -58.4% | -100.0% | — |
| Cost of revenue | — | — | $2.26M | $7.16M | $8.24M | $80382.00 | $84071.00 | $94046.00 |
| Gross profit | $20609.00 | $41301.00 | $28881.00 | $-7.03M | $-8.11M | $55180.00 | $-84071.00 | $-94046.00 |
| Gross margin | 100.0% | 100.0% | 100.0% | -5249.3% | -6114.6% | 100.0% | — | — |
| R&D | $826880.00 | $1.59M | $2.26M | $7.35M | $8.46M | $11.52M | $10.79M | $10.21M |
| SG&A | $222047.00 | $555165.00 | $1.25M | $6.83M | $9.45M | $10.79M | $9.56M | $8.50M |
| Operating income | $-1.03M | $-2.10M | $-3.48M | $-13.83M | $-17.78M | $-22.25M | $-20.35M | $-18.71M |
| Operating margin | -4989.7% | -5084.9% | -12047.5% | -10323.6% | -13402.5% | -40328.3% | — | — |
| EBITDA | $-1.03M | $-2.10M | $-3.47M | $-13.82M | $-17.76M | $-22.17M | $-20.27M | $-18.62M |
| EBITDA margin | -4986.1% | -5078.7% | -12014.3% | -10320.5% | -13390.1% | -40176.8% | — | — |
| EBIT | $-1.03M | $-2.10M | $-3.48M | $-13.84M | $-17.79M | $-22.25M | $-20.35M | $-18.71M |
| Interest expense | $52477.00 | $20540.00 | $189331.00 | $117861.00 | $247377.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.11M | $-2.19M | $-3.58M | $-13.89M | $-17.59M | $-22.27M | $-20.41M | $-20.16M |
| Net income growth (YoY) | — | -98.4% | -63.1% | -288.3% | -26.6% | -26.6% | +8.3% | +1.2% |
| Profit margin | -5364.4% | -5310.9% | -12387.7% | -10371.7% | -13262.0% | -40354.3% | — | — |